2nd International Congress on Psychopharmacology

Neurochemical modulation of fronto-executive function: Implications for neuropsychiatry

Human models of anxiety; implications for current and future therapeutics

Schizophrenia and mood disorder spectrums: similarities and differentiates.

New anticonvulsants in bipolar disorders : When, which ones, and how long are they prescribed?

New antipsychotics in bipolar disorders: When, which ones, and how long are they prescribed?

Treatment-resistance concept in mood disorders: What are the pathophysiologies of mood disorders? Add-on therapies in mood disorders : When, which ones, and how long are they required?

Bipolar disorder in adolescence: Current treatment modalities.

Maintenance treatment in bipolar disorder: Comparison of evidence based results and clinical practice

Neural and neurochemical substrates of impulsivity and compulsivity

New psychopharmacology of depression: implications for current and future therapeutics

Current opinions on psychoanalytic therapies in the treatment of psychiatric disorders

CBT as an evidence-based therapeutic approach and difficulties in its application

Is pharmacotherapy an obstacle for psychotherapy or not?

Is hypnosis a forgotten model of treatment? Availability of hypnotherapy in the psychiatric disorders

Psychotherapy and EMDR in the perspective of psychotraumatology

Current approaches in the treatment of alcoholism.

Current psychopharmacological approaches in the treatment of opiate addiction.

Current psychopharmacological approaches in the treatment of cannabis dependency.

Current psychopharmacological approaches in the treatment of cocaine and other stimulant addictions.

Current psychopharmacological approaches in the treatment of nicotine dependency.

Current psychopharmacological approaches in the treatment of other psychoactive substance addictions.

Practical clinical approaches to the treatment of refractory schizophrenia: Current developments in description, diagnosis, and pharmacotherapy

Metabolic syndrome in the light of current literature.

The genetics of the side effects of new antipsychotic: Is it possible to predict the side effects?

Are the diabetogenic side effects of new antipsychotics independent of their obesity causing side effects?

The effects of new antipsychotics on lipid profiles and their cardiac side effects.

Hormonal side effects of new antipsychotics.

Neuropsychoimmunology in therapeutic psychiatry: Recent advances

New psychopharmacology of bipolar disorder; implications for current and future therapeutics

Neuroplasticity and psychotropic medications

Do the effects of psychotropics on developing brain cause a drawback or enhance plasticity and genetics?

Neurotrophic mechanisms and antidepressants

Neurotrophic mechanisms and mood stabilizers

Neurotrophic mechanisms and antipsychotics

Neuroprotective and brain repairing drugs in therapeutic psychiatry: Recent Advances

Rational and therapeutic choices in child and adolescent psychopharmacology

Rational antidepressant treatment from the point of view of evidence-based psychiatry

The interactions of genetics and environment in schizophrenia.

BDNF and psychiatric disorders related to stress.

Oxidative stress and its clinical implications.

Cytokines, stress, and depression

Effects of psychotropics on developing brain.

Brain imaging changes of pre- and post-treatment periods of anxiety disorders.

Psychosocial factors in schizophrenia

Family studies in schizophrenia

Genetics and cognitive function interactions in schizophrenia

Pharmacogenetic developments in schizophrenia

Psychomotor side effects and results of psychotropics and other drugs on pilots and flight crew.

Psychomotor side effects and results of psychotropics and other drugs on drivers.

Psychomotor side effects and results of psychotropics and other drugs on submarine crew and divers.

Psychomotor side effects and results of psychotropics and other drugs on workers.

Side effects of psychotrpics prescribed for children and adolescents on their psychomotor and cognitive functioning.

Psychopharmacotherapeutic approaches in children and adolescents: An update

Genetic risk factors in schizophrenia

First episode in schizophrenia.

Evaluation of prodromal schizophrenia.

Psychoharmacotherapeutic approaches in prodromal schizophrenia.

Treatment of first episode in schizophrenia.

The prognosis of first episode in schizophrenia: Can it be predict?

Psychopharmacogenetics.

Future psychotropic medications.

Benzodiazepinophobia or benzodiazepinophilia?

Life threatening interactions of psychotropic medications.

Adherence problems in psychopharmacotherapy: Results and managements.

Common methods in psychopharmacological researches; possible problems and its managements

Neuroprotective and brain repairing drugs in therapeutic psychiatry: Recent Advances

Is ADHD a real or fictitious diagnostic category? Did prevalence of of ADHD increase in recent years? Current approaches in the treatment and pathophysiology of ADHD.

Pharmacogenetics in the treatment of ADHD.

The outcomes of short-acting and long-acting use of stimulants in the treatment ADHD, dependance and other complications. Do ADHD patients need a lifelong treatment?

The use of psychotropics other than stimulants in the treatment of ADHD, new line psychotropics, and complications. Do we need stimulants besides all the risks?

Comorbidity, clinical picture, treatment modalities, medication interactions of ADHD in childhood and adolescence.

Brain mechanisms of antisocial personality disorder

Neuropsychoimmunology in psychiatry.

Neurobiology of social cognition.

Advances in neurobiology of schizophrenia.

Pathogenesis of schizophrenia: Glutamate or dopamine.

New evidence in the role of cholinergic system on affective disorders.

Dopaminergic system and addiction.

Schizophrenia and the solitary route to rational antipsychotic medication

New Psychopharmacology of anxiety disorders; Implications for current and future therapeutics

Serious drug interactions in psychiatric practice

The use of psychotropics during pregnancy: Effects on developing embryo-fetus.

New antipsychotics in terms of their pharmacoeconomy

Their use on schizophrenia and other psychotic disorders.

Their use on mood disorders

Their use on anxiety disorders

Their use on dementia and other cognitive disorders.

Serious side effects of new antipsychotics and management strategies

The use of neurocognitive tests on dementia.

Rational use of cholinesterase inhibitors in the treatment of cognitive symptoms in dementia.

Rational use of cholinesterase inhibitors in the treatment of psychological and behavioral tretament in dementia.

The use of antipsychotic medications in the treatment in dementia.

Rational use of other antidementia medications in the treatment in dementia.

Neuroimaging in psychiatry

The effects of psychotropics on learning and memory.

Research findings on oxidative stress-1.

Research findings on oxidative stress-2.

Relationships of oxidant-antioxidant systems to diseases

Relationships of oxidant-antioxidant systems to psychiatric disorders.

Developments in the pathogenesis of the eating disorders in the light of current literature.

The pandemic of obesity: Are eating disorders an addiction?

Anorexia Nervosa: An adolescence disease?

Binge-eating: Towards obesity epidemic?

Iatrogenic eating disorders: How guilty are psychotropics? Managements of weight gaining caused by psychotropics

Psychopharmacological treatment approaches in eating disorders

Psychopharmacological approaches in old age

Ethical principles in clinical researches and their worldwide applications

Potential conflicts of interest academic-industry relationships in a new age of partnerships and potential conflicts of interest

Government-Academia-Industry partnerships to develop new therapeutics for neuropsychiatric disorders.

How reliable are the research findings? Are the researches enough to get licensed?

Manipulation attempts of pharmaceuthical companies and precautions

Antidementia medications: Are they effective? Which medication at which phase? Medication combinations and medications interactions.

Approaches to deal with the emergency situations and agitations in dementia.

The use of atypical antipsychotics on the treatment of delusions and hallucinations of dementia: Effective or not?

Resistant depression in dementia and treatment approaches.

Alternative drug therapies ( sleep pills, benzodiazepines, antidepressants, melathonin, valerian, etc.) of sleep disorders in aging and dementia.

Treatment and life quality of resistant generalized eanxiety disorders.

Treatment and life quality of resistant panic disorder.

Treatment and life quality of resistant PTSD.

Treatment approaches and combinations in OCD and resistant depression comorbidity.

Neurobiological factors of suicidal behavior in schizoobsessif disorder.

The place of psychosurgery in resistant OCD